Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus

NCT00005878 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: celecoxib

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]